Chicago, IL, United States of America

Stephen Maxwell Karesh

This inventor holds 1 USPTO granted patent. Top assignee: Capintec, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen Maxwell Karesh

Introduction

Stephen Maxwell Karesh is an accomplished inventor based in Chicago, Illinois. He is known for his significant contributions to the field of medical technology, particularly in the development of innovative tools for biopsy localization.

Latest Patents

Karesh holds a patent for a radioactive needle designed for biopsy localization. This needle is tipped with a plating of radioactive metal and is covered with additional layers to prevent the rubbing off of radioactive material. This design decreases local or systemic reactions to the plating materials and prevents the decomposition of the underlying plating. The radioactive-tipped needle can be utilized alongside nuclear medicine imaging techniques to identify and localize abnormalities that may not be visible through other radiographic methods. A method for producing this needle is also described in his patent.

Career Highlights

Karesh is currently employed at Capintec, Inc., where he continues to innovate in the medical technology sector. His work has had a profound impact on the way biopsies are performed, enhancing the accuracy and safety of the procedure.

Collaborations

One of his notable coworkers is Robert Hans Wagner, with whom he has likely collaborated on various projects within the company.

Conclusion

Stephen Maxwell Karesh's contributions to medical technology, particularly through his patented radioactive needle, demonstrate his commitment to improving healthcare practices. His work continues to influence the field and enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…